live In the news:
Africa may need its own central medicines agency, says Aspen Pharmacare CEO / Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom / FDA to undo some layoffs, after cuts to inspections and drug safety / Employers are spending more on GLP-1 drugs, but the ROI is already here / Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs / Drugs giant GSK 'well positioned' to absorb potential US tariffs / US, Japan drugmakers target ALS-causing genes with new therapies / Merck to invest $1 billion in U.S. drug manufacturing plant / Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs / Singapore negotiating for U.S. concessions on pharmaceuticals, chips

Pharmaceuticals

Updated: 11h ago
bookmarkBookmark

Pharmaceuticals is an industry. It includes 12,231 companies, employing 6,922,050 individuals. The total assets amount to 2,291.1B $, generating revenues of 2,108.6B $ and profits of 162.5B $, while total debt stands at 681.9B $.

Key facts

  • companies: 12,231
  • employees: 6,922,050 people
  • revenues: 2,108.6B $
  • assets: 2,291.1B $
  • profits: 162.5B $
  • debt: 681.9B $

Extract data

Download datasets about Pharmaceuticals:

dataset Dataset of Pharmaceuticals companies :

Pharmaceuticals is one of the 71 industries in our database.

Visualize data

Get charts or maps on Pharmaceuticals:

Distribution of companies in Pharmaceuticals by foundation year

Share of company types in the Pharmaceuticals industry

Share of revenue types by companies in the Pharmaceuticals industry

Share of employee types in companies in the Pharmaceuticals industry

Share of CEOs per gender in the Pharmaceuticals industry

Correlation of environmental score and governance score (ESG) of companies in the Pharmaceuticals industry

Correlation of employees and revenues of companies in the Pharmaceuticals industry

Related

Connected or similar to Pharmaceuticals: .

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.